Hypertension in adults: diagnosis and management

with cardiovascular disease. Full details of the evidence and the committee's discussion are in the evidence review K: pharmacological treatment in cardiovascular disease. Step 1 treatment 1.4.32 Offer an ACE inhibitor or an ARB to adults starting step 1 antihypertensive treatment who: • have type 2 diabetes and are of any age or family origin (see also recommendation 1.4.30 for adults of Black African or African–Caribbean family origin) or • are aged under 55 but not of Black African or African–Caribbean family origin. [2019] Follow the MHRA safety advice on ACE inhibitors and angiotensin II receptor antagonists: not for use in pregnancy, how to use for breastfeeding and clarification on breastfeeding. 1.4.33 If an ACE inhibitor is not tolerated, for example because of cough, offer an ARB to treat hypertension. [2019] Follow the MHRA safety advice on ACE inhibitors and angiotensin II receptor antagonists: not for use in pregnancy, how to use for breastfeeding and clarification on breastfeeding. 1.4.34 Do not combine an ACE inhibitor with an ARB to treat hypertension. [2019] 1.4.35 Offer a calcium-channel blocker (CCB) to adults starting step 1 antihypertensive treatment who: • are aged 55 or over and do not have type 2 diabetes or
